Evidence map›Paper›PMID 36171079›Full record

ReviewGut2023

Advancing human gut microbiota research by considering gut transit time.

Nicola Procházková, Gwen Falony, Lars Ove Dragsted, Tine Rask Licht, Jeroen Raes, Henrik M Roager

Registry-linked trialAbstract readReview
In one paragraph

Review in Gut, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06340217 (The Efficacy and Safety of WMT in the Treatment of Diabetic Gastroparesis), which is not on this map. Cited by 179 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
179citing papers in PubMed, 4 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06340217 narecruitingnot on this mapstarted 2024, after this paper: background citation

The Efficacy and Safety of WMT in the Treatment of Diabetic Gastroparesis: A Multicenter, Randomized, Double-blind, Placebo-controlled Study

TypeinterventionalSponsorThe Second Hospital of Nanjing Medical UniversityRan2024 to 2029Enrolled46ConditionsDiabetic GastroparesisArmswashed microbiota transplantation, placebo
3 · Its place in the literature

Who cites it

179 citing papers in PubMed, 4 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Trial
  6. Trial
  7. Trial
  8. Trial
  9. Trial
  10. Trial
  11. Trial
  12. Trial
  13. Article
  14. Review
  15. Article
  16. Extracellular metabolite production byApplied and environmental microbiology · 2026
    Article
  17. Review
  18. Review
  19. Review
  20. Review

119 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Nicola ProcházkováDepartment of Nutrition, Exercise and Sports, University of Copenhagen, Frederiksberg, Denmark.ORCID 0000-0002-1071-2488
Gwen FalonyDepartment of Microbiology and Immunology, KU Leuven - University of Leuven, Leuven, Belgium.
Lars Ove DragstedDepartment of Nutrition, Exercise and Sports, University of Copenhagen, Frederiksberg, Denmark.ORCID 0000-0003-0609-6317
Tine Rask LichtNational Food Institute, Technical University, Kgs. Lyngby, Denmark.ORCID 0000-0002-6399-9574
Jeroen RaesDepartment of Microbiology and Immunology, KU Leuven - University of Leuven, Leuven, Belgium.
Henrik M RoagerDepartment of Nutrition, Exercise and Sports, University of Copenhagen, Frederiksberg, Denmark hero@nexs.ku.dk.ORCID 0000-0002-2504-8313

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Accumulating evidence indicates that gut transit time is a key factor in shaping the gut microbiota composition and activity, which are linked to human health. Both population-wide and small-scale studies have identified transit time as a top covariate contributing to the large interindividual variation in the faecal microbiota composition. Despite this, transit time is still rarely being considered in the field of the human gut microbiome. Here, we review the latest research describing how and why whole gut and segmental transit times vary substantially between and within individuals, and how variations in gut transit time impact the gut microbiota composition, diversity and metabolism. Furthermore, we discuss the mechanisms by which the gut microbiota may causally affect gut motility. We argue that by taking into account the interindividual and intraindividual differences in gut transit time, we can advance our understanding of diet-microbiota interactions and disease-related microbiome signatures, since these may often be confounded by transient or persistent alterations in transit time. Altogether, a better understanding of the complex, bidirectional interactions between the gut microbiota and transit time is required to better understand gut microbiome variations in health and disease.

Indexed as

Gastrointestinal MicrobiomeMicrobiotaDietFecesHumansdietgastrointestinal physiologygastrointestinal transitintestinal microbiology

Identifiers

PMID36171079
PMCPMC9763197

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.